• Myeloma UK
  • Clinical Service Excellence Programme
Myeloma Academy
Sign inRegister
Menu
  • Home
  • CPD & Learning
    • Myeloma Nurse Learning Programme
    • My CPD Portfolio
    • Challenging Cases
    • Close
  • Library
    • Guidelines
      • Complications
      • COVID-19 guidance
      • General haemato/oncology
      • Imaging & Analysis
      • Management & Treatment
      • Palliative Care
      • Presentation & Diagnosis
      • Related conditions
      • Close
    • Patient Support and Information
    • Medical animations
    • Remote consultation video
    • Close
  • Resources
    • Myeloma Drug Finder
    • Myeloma Trial Finder
    • Assessment tools
    • Myeloma Spotlight
    • Primary care education
    • Secondary care education
    • Myeloma Nurse Guides
    • Myeloma health economic model
    • Laboratory Practice
    • Close
  • News & Events
    • News
    • Event calendar
    • Meeting highlights
    • Close
  • CSEP
  • About Us
    • Contact Us
    • Close
Menu back  
 

Diagnostic tests and prognostic indicators

Predicting multiple myeloma disease activity by analyzing natural calcium isotopic composition.
Gordon GW et al. Leukemia. 2014 Jun 12. doi: 10.1038/leu.2014.193. [Epub ahead of print].

Identification of cereblon binding proteins and relationship with response and survival following pomalidomide and dexamethasone in multiple myeloma.
Zhu YX et al. Blood. 2014 Jun 9. pii: blood-2014-02-557819. [Epub ahead of print].

Prognostic impact of angiopoietin-2 in multiple myeloma.
Pappa CA et al. J Cancer Res Clin Oncol. 2014 Jun 8. [Epub ahead of print].

Combination of International Scoring System 3, High Lactate Dehydrogenase, and t(4;14) and/or del(17p) Identifies Patients With Multiple Myeloma (MM) Treated With Front-Line Autologous Stem-Cell Transplantation at High Risk of Early MM Progression-Related Death.
Moreau P et al. J Clin Oncol. 2014 Jun 2. pii: JCO.2013.53.0329. [Epub ahead of print].

  • Guidelines
  • Patient Support and Information
  • Medical animations
  • Remote consultation video
Bottom menu

Charity No. SC 026116
Myeloma UK
22 Logie Mill
Beaverbank Business Park
Edinburgh
EH7 4HG